X
Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
I UNDERSTAND
English Section

EU says strikes deal with Sanofi for coronavirus vaccine

02.08.2020 13:00
The European Commission said on Friday it has struck a deal with French pharma giant Sanofi to buy 300 million doses of a future coronavirus vaccine.
Medical staff at work in one of the hospitals in Warsaw.
Medical staff at work in one of the hospitals in Warsaw.Photo: PAP/Leszek Szymański

“The envisaged contract with Sanofi would provide for an option for all EU Member States to purchase the vaccine,” the European Commission said in a statement.

It added that “once a vaccine has proven to be safe and effective against COVID-19, the Commission would have a contractual framework in place for the purchase of 300 million doses, on behalf of all EU member states.”

The European Commission, equipped with an emergency fund of EUR 2 billion (USD 2.4 billion), aims to strike similar deals with up to six pharmaceutical companies to secure vaccines for its 450 million citizens in a bid to fight COVID-19, which has now killed over 685,000 people worldwide.

European Commission President Ursula von der Leyen said that "while we do not know today which vaccine will work best in the end, Europe is investing in a diversified portfolio of promising vaccines, based on various types of technologies."

"This increases our chances to obtain rapidly an effective remedy against the virus. A vaccine would be a truly global good," she added.

Sanofi is currently working on two vaccines, including one in partnership with GlaxoSmithKline, Reuters news agency reported.

The companies said the vaccine would be manufactured in France, Belgium, Germany and Italy.

Sanofi expects to start clinical trials in September.

Active coronavirus cases soar in Poland, officials said, with 548 new infections reported on Sunday.

On Saturday, the country reported its highest number of new cases for a third day in a row.

A total of 46,894 people have tested positive for the coronavirus in Poland since early March, with 1,731 deaths from the COVID-19 respiratory disease so far.

(jh)

Source: PAP, Reuters